We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.
- Authors
Lennon, Vanda A; Wingerchuk, Dean M; Kryzer, Thomas J; Pittock, Sean J; Lucchinetti, Claudia F; Fujihara, Kazuo; Nakashima, Ichiro; Weinshenker, Brian G
- Abstract
Neuromyelitis optica is an inflammatory demyelinating disease with generally poor prognosis that selectively targets optic nerves and spinal cord. It is commonly misdiagnosed as multiple sclerosis. Neither disease has a distinguishing biomarker, but optimum treatments differ. The relation of neuromyelitis optica to optic-spinal multiple sclerosis in Asia is uncertain. We assessed the capacity of a putative marker for neuromyelitis optica (NMO-IgG) to distinguish neuromyelitis optica and related disorders from multiple sclerosis.
- Publication
Lancet (London, England), 2004, Vol 364, Issue 9451, p2106
- ISSN
1474-547X
- Publication type
Journal Article
- DOI
10.1016/S0140-6736(04)17551-X